Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2018 08:00 ET | Source: resTORbio, Inc.

resTORbio to Present at the 2018 RBC Capital Markets Global Healthcare Conference

BOSTON, Feb. 20, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
January 30, 2018 16:01 ET | Source: resTORbio, Inc.

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the...
January 25, 2018 19:55 ET | Source: resTORbio, Inc.

resTORbio Announces Pricing of Initial Public Offering

BOSTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of...